Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy Finke

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|April 23, 2014
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patientsAyalew Tefferi, Emnet A Wassie, Paola Guglielmelli, et al.
Blood Advances|April 2, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significanceMarissa Li, Anmol Baranwal, Mark Gurney, et al.
Leukemia|July 8, 2023
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, et al.
Haematologica|December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancerOlisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.
British Journal of Haematology|March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeYael Kusne, Talha Badar, Terra Lasho, et al.
Leukemia|February 16, 2020
Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasmsEmma C DiFilippo, Giacomo Coltro, Ryan M Carr, et al.
Haematologica|May 18, 2023
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasmsTalha Badar, Ahmad Nanaa, James M Foran, et al.
Blood|July 20, 2014
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosisAyalew Tefferi, Paola Guglielmelli, Dirk R Larson, et al.
Mayo Clinic Proceedings|March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease SubgroupsNatasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Blood Advances|April 27, 2021
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patientsMarissa Li, Moritz Binder, Terra Lasho, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|April 23, 2014
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patientsAyalew Tefferi, Emnet A Wassie, Paola Guglielmelli, et al.
Blood Advances|April 2, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significanceMarissa Li, Anmol Baranwal, Mark Gurney, et al.
Leukemia|July 8, 2023
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML)Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, et al.
Haematologica|December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancerOlisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.
British Journal of Haematology|March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeYael Kusne, Talha Badar, Terra Lasho, et al.
Leukemia|February 16, 2020
Spectrum of abnormalities and clonal transformation in germline RUNX1 familial platelet disorder and a genomic comparative analysis with somatic RUNX1 mutations in MDS/MPN overlap neoplasmsEmma C DiFilippo, Giacomo Coltro, Ryan M Carr, et al.
Haematologica|May 18, 2023
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasmsTalha Badar, Ahmad Nanaa, James M Foran, et al.
Blood|July 20, 2014
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosisAyalew Tefferi, Paola Guglielmelli, Dirk R Larson, et al.
Mayo Clinic Proceedings|March 3, 2019
3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease SubgroupsNatasha Szuber, Mythri Mudireddy, Maura Nicolosi, et al.
Blood Advances|April 27, 2021
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patientsMarissa Li, Moritz Binder, Terra Lasho, et al.
Pageof 6